Quidel Corporation - News Releases

2019 2018 2017 2016 2015 2014

12/17/2014

Quidel Receives Simultaneous FDA Clearance and CLIA Waiver for Its Sofia(R) Strep A+ Fluorescent Immunoassay (FIA) via the FDA's New Dual Submission Program

12/10/2014

Quidel Receives FDA Clearance for Its AmpliVue(R) Hand-Held Molecular Diagnostic Test for Bordetella Pertussis

12/02/2014

Quidel Announces Pricing of $150 Million Convertible Senior Notes Offering

12/01/2014

Quidel Announces Proposed Offering of $150 Million of Convertible Senior Notes

11/18/2014

Dr. Kenneth J. Widder Joins Quidel's Board of Directors

10/21/2014

Quidel Reports Third Quarter 2014 Financial Results

10/15/2014

Quidel Receives FDA Clearance for Its Lyra(TM) Molecular PCR Assay for the Detection of Human Parainfluenza Viruses (HPIV), Types 1, 2 and 3

10/13/2014

Quidel Receives FDA Clearance for Its Lyra(R) Molecular PCR Assay for the Detection of Adenovirus

10/06/2014

Quidel to Hold Third Quarter 2014 Financial Results Conference Call on October 21, 2014

08/22/2014

Quidel to Present at Baird 2014 Health Care Conference

07/28/2014

Quidel Receives FDA Clearance for Its Hand-Held Molecular Diagnostic Test for Group A Strep

07/22/2014

Quidel Reports Second Quarter 2014 Financial Results

07/08/2014

Quidel to Hold Second Quarter 2014 Financial Results Conference Call on July 22, 2014

06/04/2014

Quidel to Present at Wells Fargo Securities 2014 Healthcare Conference

06/02/2014

Quidel Receives CLIA Waiver for Its Sofia(R) Diagnostic Test for Respiratory Syncytial Virus (RSV)

05/14/2014

Quidel Receives FDA Clearance for Its Molecular PCR Assay for the Detection of Herpes Simplex Virus 1+2 and Varicella Zoster Virus

04/29/2014

Quidel to Present at Bank of America Merrill Lynch 2014 Health Care Conference

04/23/2014

Quidel Reports First Quarter 2014 Financial Results

04/22/2014

Quidel Receives FDA Clearance for Its Lyra(TM) Molecular PCR Assay for the Detection of Infections From Pyogenic Streptococcus Group A and C or G

04/15/2014

Quidel to Hold First Quarter 2014 Financial Results Conference Call on April 23, 2014

03/27/2014

Quidel Receives FDA Clearance for Its AmpliVue(R) Hand-Held Molecular Diagnostic Test for Herpes Simplex Virus Types 1 and 2

02/18/2014

Quidel to Present at Cowen 34th Annual Health Care Conference

02/11/2014

Quidel Reports Fourth Quarter and Full Year 2013 Financial Results

01/28/2014

Quidel to Hold Fourth Quarter and Full Year 2013 Financial Results Conference Call on February 11, 2014

01/08/2014

Quidel Announces Preliminary Revenue for Fourth Quarter 2013